CMPX
Compass Therapeutics Inc.
1.10$
-0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -7.7% | +2.7% | -3.4% | -4.2% | -5.9% | -6.4% | -11.2% | +98.2% | -5.0% | -6.6% | -7.3% | |
| – | -7.6% | +3.1% | -3.2% | -8.1% | -5.9% | -6.5% | -14.5% | +108.2% | -5.1% | -6.7% | -7.6% | |
| – | -20.4% | -2.3% | -18.0% | +89.7% | +18.2% | -5.6% | -44.3% | +102.2% | -33.7% | +80.0% | -35.7% | |
| – | -6.9% | +2.5% | -6.4% | -7.4% | -6.4% | -11.1% | -10.4% | +117.8% | -5.0% | -6.8% | -7.6% | |
| – | -16.6% | -51.0% | +132.9% | +13.1% | +41.1% | +39.6% | +11.0% | -7.9% | +5.3% | -18.0% | +29.0% | |
| – | -14.5% | -50.1% | +144.2% | -53.4% | +100.2% | +67.9% | -7.0% | -10.4% | +12.5% | -26.4% | +56.9% | |
| – | +2.0% | +2.3% | -11.1% | -48.8% | -39.3% | -67.8% | +148.6% | +133.6% | +58.0% | +37.3% | +19.2% | |
| – | +77.4% | -79.1% | +39.6% | -19.5% | +134.3% | -29.9% | +64.6% | +19.3% | -48.8% | -42.8% | +220.8% | |
| – | -7.2% | +5.7% | -7.0% | -5.3% | -9.5% | -11.9% | -15.5% | +124.9% | -6.1% | -5.2% | -11.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | +7.0% | +0.7% | +0.0% | -0.7% | +1.2% | +0.0% | +0.0% | +33.7% | +0.8% | +0.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.